Suli Jiang

428 total citations
17 papers, 315 citations indexed

About

Suli Jiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Suli Jiang has authored 17 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Suli Jiang's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Suli Jiang is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Suli Jiang collaborates with scholars based in China. Suli Jiang's co-authors include Suyun Li, Yange Tian, Jiansheng Li, Ya Li, Ying Wang, Li Deng, Yuanyuan Wang, Meiying Song, Luoyang Wang and Yanyan Yang and has published in prestigious journals such as European Journal of Pharmacology, Clinical & Experimental Immunology and Molecular Immunology.

In The Last Decade

Suli Jiang

17 papers receiving 313 citations

Peers

Suli Jiang

PRM

IMMUN

CAM

PHYSI

Dong-Gyu Kim South Korea

Suidong Ouyang China

Chengshi Wang China

Maha Farid United States

Hongfeng Liang China

Kiranj Chaudagar United States

Zhiju Wang China

Jia‐Wen Xu China

Zhanfei Li China

Dong-Gyu Kim South Korea

Suli Jiang

123 ×1.1

137 ×1.4

PRM

33 ×0.5

IMMUN

20 ×0.4

CAM

62 ×1.4

PHYSI

Citations per year, relative to Suli Jiang Suli Jiang (= 1×) peers Dong-Gyu Kim

Countries citing papers authored by Suli Jiang

Since Specialization

Citations

This map shows the geographic impact of Suli Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suli Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suli Jiang more than expected).

Fields of papers citing papers by Suli Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suli Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suli Jiang. The network helps show where Suli Jiang may publish in the future.

Co-authorship network of co-authors of Suli Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Suli Jiang. A scholar is included among the top collaborators of Suli Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suli Jiang. Suli Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Liu, Guixian, Wei Li, Suli Jiang, et al.. (2025). ARA290, an alternative of erythropoietin, inhibits activation of NLRP3 inflammasome in schwann cells after sciatic nerve injury. European Journal of Pharmacology. 997. 177610–177610. 1 indexed citations

Liu, Guixian, et al.. (2024). The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injury. International Immunopharmacology. 138. 112452–112452. 3 indexed citations

Jiang, Suli, Wei Li, Meiying Song, et al.. (2024). CXCL1-CXCR2 axis mediates inflammatory response after sciatic nerve injury by regulating macrophage infiltration. Molecular Immunology. 169. 50–65. 8 indexed citations

Song, Meiying, Luoyang Wang, Suli Jiang, et al.. (2024). Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma. International Immunopharmacology. 129. 111601–111601. 8 indexed citations

Song, Meiying, Jie Liang, Luoyang Wang, et al.. (2023). IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment. International Immunopharmacology. 123. 110757–110757. 30 indexed citations

Jiang, Suli, Jie Liang, Wei Li, et al.. (2023). The role of CXCL1/CXCR2 axis in neurological diseases. International Immunopharmacology. 120. 110330–110330. 21 indexed citations

Wang, Luoyang, Lei Tang, Meiying Song, et al.. (2023). The role of the sex hormone-gut microbiome axis in tumor immunotherapy. Gut Microbes. 15(1). 2185035–2185035. 18 indexed citations

Li, Wei, Jie Liang, Shaohua Li, et al.. (2023). The CXCL12-CXCR4-NLRP3 axis promotes Schwann cell pyroptosis and sciatic nerve demyelination in rats. Clinical & Experimental Immunology. 214(2). 219–234. 6 indexed citations

Li, Wei, Jie Liang, Shaohua Li, et al.. (2022). Research progress of targeting NLRP3 inflammasome in peripheral nerve injury and pain. International Immunopharmacology. 110. 109026–109026. 37 indexed citations

10.

Tian, Yange, Ya Li, Jiansheng Li, et al.. (2015). Effects of therapies for regulating and reinforcing lung and kidney on osteoporosis in rats with chronic obstructive pulmonary disease. Journal of Traditional Chinese Medicine. 35(2). 175–183. 4 indexed citations

11.

Yang, Liping, Jiansheng Li, Ya Li, et al.. (2015). Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS. Evidence-based Complementary and Alternative Medicine. 2015. 1–9. 15 indexed citations

12.

Li, Ya, Jiansheng Li, Weiwei Li, et al.. (2014). Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease. BMC Complementary and Alternative Medicine. 14(1). 140–140. 40 indexed citations

13.

Fang, Jie, et al.. (2014). Intravenous dezocine pretreatment reduces the incidence and intensity of myoclonus induced by etomidate. Journal of Anesthesia. 28(6). 944–947. 15 indexed citations

14.

Li, Jiansheng, Liping Yang, Ya Li, et al.. (2014). Metabolomics study on model rats of chronic obstructive pulmonary disease treated with Bu-Fei Jian-Pi. Molecular Medicine Reports. 11(2). 1324–1333. 16 indexed citations

15.

Yang, Liping, Qin Yao, Ya Li, et al.. (2014). Effects and Mechanism of Bufei Yishen Formula in a Rat Chronic Obstructive Pulmonary Disease Model. Evidence-based Complementary and Alternative Medicine. 2014(1). 381976–381976. 11 indexed citations

16.

Jiang, Suli, Ya Li, Suyun Li, et al.. (2013). [Influence and long-term effects of three methods for regulating and invigorating fei-shen on T lymphocyte subsets and CD4+ CD25+ in COPD rats].. PubMed. 33(11). 1538–44. 4 indexed citations

17.

Li, Ya, Suyun Li, Jiansheng Li, et al.. (2012). A Rat Model for Stable Chronic Obstructive Pulmonary Disease Induced by Cigarette Smoke Inhalation and Repetitive Bacterial Infection. Biological and Pharmaceutical Bulletin. 35(10). 1752–1760. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact